SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (9)12/21/1996 9:46:00 PM
From: Fred Zhang   of 4474
 
Rick, Great analysis. Recently, I moved to Boston/Cambridge area and
happened to get an investor package from Ariad. I am not a biology
guru by any means, but my wife is. She immediately recognized those
big names on their scientific board and great technology they licensed
from Harvard/MIT/Stanford. As a matter of fact, she is working on
gene regulation and chemical biology and probably will collaborate with
a couple of guys from their scientific board. We both are very impressed
with this company TECHNOLOGY WISE. From investment stand point of view,
I think that it will take long time for the company to cash in their
technology and make their stock take off. If you are long term investor,
this should be a good buy although some news may push the stock up sharply
tempararily in the near future.

by the way, Ariad is within working distance from where I work and I
may stop by someday to check the company(great location at University
Park near MIT).

Disclaimer: I do NOT own any ARIA at this moment and this is my own
option and do your own research.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext